{"result": "(\"entity\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>EVENT<|>Idiopathic Pulmonary Fibrosis is a disease characterized by progressive scarring of lung tissue, leading to respiratory difficulties and various symptoms.)\n##\n(\"entity\"<|>ANOXIA<|>EVENT<|>Anoxia is a condition characterized by an absence of oxygen in the tissues, which can be a symptom of Idiopathic Pulmonary Fibrosis.)\n##\n(\"entity\"<|>COUGH<|>EVENT<|>Cough is a common symptom associated with Idiopathic Pulmonary Fibrosis, often resulting from lung irritation.)\n##\n(\"entity\"<|>DYSPNEA<|>EVENT<|>Dyspnea refers to difficulty in breathing, a prevalent symptom of Idiopathic Pulmonary Fibrosis.)\n##\n(\"entity\"<|>HEARTBURN<|>EVENT<|>Heartburn is a symptom that may occur in patients with Idiopathic Pulmonary Fibrosis, potentially due to related respiratory issues.)\n##\n(\"entity\"<|>RESPIRATORY SOUNDS<|>EVENT<|>Respiratory sounds are abnormal sounds heard during breathing, which can indicate complications associated with Idiopathic Pulmonary Fibrosis.)\n##\n(\"entity\"<|>SLEEP APNEA SYNDROMES<|>EVENT<|>Sleep Apnea Syndromes are conditions that can occur in patients with Idiopathic Pulmonary Fibrosis, affecting their sleep quality and breathing.)\n##\n(\"entity\"<|>AGING, PREMATURE<|>EVENT<|>Aging, Premature refers to early onset of aging symptoms, which can be associated with Idiopathic Pulmonary Fibrosis.)\n##\n(\"entity\"<|>SLEEP APNEA, OBSTRUCTIVE<|>EVENT<|>Obstructive Sleep Apnea is a specific type of sleep apnea that can be a symptom in patients with Idiopathic Pulmonary Fibrosis.)\n##\n(\"entity\"<|>RESPIRATORY SYSTEM<|>GEO<|>The Respiratory System is the part of the human body where Idiopathic Pulmonary Fibrosis localizes, affecting breathing and gas exchange.)\n##\n(\"entity\"<|>PULMONARY ARTERY<|>GEO<|>The Pulmonary Artery is a major blood vessel that can be affected by Idiopathic Pulmonary Fibrosis, impacting blood flow to the lungs.)\n##\n(\"entity\"<|>LUNG<|>GEO<|>The Lung is the primary organ affected by Idiopathic Pulmonary Fibrosis, where scarring and inflammation occur.)\n##\n(\"entity\"<|>ALVEOLUS OF LUNG<|>GEO<|>The Alveolus of Lung is the tiny air sac in the lungs where gas exchange occurs, and is significantly impacted by Idiopathic Pulmonary Fibrosis.)\n##\n(\"entity\"<|>PREDNISOLONE<|>ORGANIZATION<|>Prednisolone is a corticosteroid medication used to palliate symptoms of Idiopathic Pulmonary Fibrosis by reducing inflammation in the lungs.)\n##\n(\"entity\"<|>CORTICOSTEROID HORMONE RECEPTOR AGONISTS<|>ORGANIZATION<|>Corticosteroid Hormone Receptor Agonists are a class of drugs that includes Prednisolone, used to treat various inflammatory conditions including Idiopathic Pulmonary Fibrosis.)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>ANOXIA<|>Anoxia is a symptom that can occur as a result of Idiopathic Pulmonary Fibrosis due to impaired oxygen exchange in the lungs.<|>8)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>COUGH<|>Cough is a common symptom experienced by patients suffering from Idiopathic Pulmonary Fibrosis.<|>8)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>DYSPNEA<|>Dyspnea is a significant symptom of Idiopathic Pulmonary Fibrosis, indicating difficulty in breathing.<|>8)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>HEARTBURN<|>Heartburn can be a symptom experienced by patients with Idiopathic Pulmonary Fibrosis, possibly due to related respiratory issues.<|>4)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>RESPIRATORY SOUNDS<|>Respiratory sounds are indicative of complications arising from Idiopathic Pulmonary Fibrosis.<|>6)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>SLEEP APNEA SYNDROMES<|>Sleep Apnea Syndromes can occur in patients with Idiopathic Pulmonary Fibrosis, affecting their overall health.<|>5)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>AGING, PREMATURE<|>Premature aging can be a consequence of the chronic nature of Idiopathic Pulmonary Fibrosis.<|>3)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>SLEEP APNEA, OBSTRUCTIVE<|>Obstructive Sleep Apnea can be a symptom in patients with Idiopathic Pulmonary Fibrosis, complicating their condition.<|>5)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>RESPIRATORY SYSTEM<|>Idiopathic Pulmonary Fibrosis primarily affects the Respiratory System, leading to various symptoms.<|>9)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>PULMONARY ARTERY<|>The Pulmonary Artery can be affected by Idiopathic Pulmonary Fibrosis, impacting blood flow to the lungs.<|>6)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>LUNG<|>The Lung is the main organ affected by Idiopathic Pulmonary Fibrosis, where the disease manifests.<|>9)\n##\n(\"relationship\"<|>IDIOPATHIC PULMONARY FIBROSIS<|>ALVEOLUS OF LUNG<|>The Alveolus of Lung is significantly impacted by Idiopathic Pulmonary Fibrosis, affecting gas exchange.<|>9)\n##\n(\"relationship\"<|>PREDNISOLONE<|>IDIOPATHIC PULMONARY FIBROSIS<|>Prednisolone is used to palliate symptoms of Idiopathic Pulmonary Fibrosis by reducing inflammation.<|>7)\n##\n(\"relationship\"<|>CORTICOSTEROID HORMONE RECEPTOR AGONISTS<|>PREDNISOLONE<|>Prednisolone is a specific drug within the class of Corticosteroid Hormone Receptor Agonists, used for treatment.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: [Idiopathic Pulmonary Fibrosis] is the name of a kind of disease.\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Anoxia].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Cough].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Dyspnea].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Heartburn].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Respiratory Sounds].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Sleep Apnea Syndromes].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Aging, Premature].\n[Idiopathic Pulmonary Fibrosis] presents the symptom [Sleep Apnea, Obstructive].\n[Idiopathic Pulmonary Fibrosis] localizes at the [Respiratory System] of human body.\n[Idiopathic Pulmonary Fibrosis] localizes at the [Pulmonary Artery] of human body.\n[Idiopathic Pulmonary Fibrosis] localizes at the [Lung] of human body.\n[Idiopathic Pulmonary Fibrosis] localizes at the [Alveolus Of Lung] of human body.\n\nThe following content describes information about compounds that can palliate or treat the disease named Idiopathic Pulmonary Fibrosis.The format of each compound's information is as follows:\nCompound name: ***\nPharmacologic class: ***\nEffect on Idiopathic Pulmonary Fibrosis: Palliate or Treat\nSide effect: ***\nThese respectively represent the name of the compound, the pharmacologic class it belongs to, its positive effect on the disease named Idiopathic Pulmonary Fibrosis (palliates or treats) and its side effects.\n\nCompound name: Prednisolone\nPharmacologic class: Corticosteroid Hormone Receptor Agonists\nEffect on Idiopathic Pulmonary Fibrosis: Palliate\nSide effect: Abdominal distension, Abscess, Hyperadrenocorticism, Anaphylactic shock, Angioedema, Arachnoiditis, Arrhythmia, Blister, Hypertrophic cardiomyopathy, Conjunctivitis\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}